Recurrent Moderate-Severe Chronic Graft Versus Host Disease
1 clinical trials · Condition
◉ Watch Recurrent Moderate-Severe Chronic Graft Versus Host Disease
| Record | Firm | Date |
|---|---|---|
| Acalabrutinib for the Treatment of Chronic Graft Versus Host Disease (NCT04198922) | Fred Hutchinson Cancer Center | 2020-12-11 |
Track Recurrent Moderate-Severe Chronic Graft Versus Host Disease automatically
Every clearance here is in the API, with alerts when new ones post.